Boston Scientific (BSX) +4.1% AH after the FDA approves its Epic vascular stent designed to open...

|About: Boston Scientific Corporation (BSX)|By:, SA News Editor

Boston Scientific (BSX) +4.1% AH after the FDA approves its Epic vascular stent designed to open blocked arteries in patients with iliac artery stenosis, a form of peripheral vascular disease associated with severe leg pain caused by insufficient blood flow.